Treatment of multiple myeloma with an allogeneic peripheral blood stem cell transplantation using a non-myeloablative conditioning regimen

被引：0
|
作者：
Kmonicek, M
Zak, P
Jebavy, L
Maisnar, V
Maly, J
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [41] Non-myeloablative peripheral blood stem cell (PBSC) allografts following cytoreductive autotransplants for treatment of multiple myeloma (MM).
    Molina, A
    Sahebi, F
    Maloney, DG
    Sandmaier, BM
    McSweeney, P
    Kashyap, A
    Bensinger, W
    Chauncey, T
    Appelbaum, FR
    Forman, SJ
    Storb, R
    BLOOD, 2000, 96 (11) : 480A - 480A
  • [42] Non-myeloablative stem cell transplantation - High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation
    Passweg, JR
    Meyer-Monard, S
    Gregor, M
    Favre, G
    Heim, D
    Ebnoether, M
    Tichelli, A
    Gratwohl, A
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 267 - 271
  • [43] Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
    de Donk, N. W. C. J. van
    Kroeger, N.
    Hegenbart, U.
    Corradini, P.
    Miguel, J. F. San
    Goldschmidt, H.
    Perez-Simon, J. A.
    Zijlmans, M.
    Raymakers, R. A.
    Montefusco, V.
    Ayuk, F. A.
    van Oers, M. H. J.
    Nagler, A.
    Verdonck, L. F.
    Lokhorst, H. M.
    BONE MARROW TRANSPLANTATION, 2006, 37 (12) : 1135 - 1141
  • [44] High-dose melphalan and autologous stem cell transplantation followed by non-myeloablative conditioning regime and allogeneic stem cell transplantation as consolidation therapy in multiple Myeloma.
    Schneider, P
    Fenk, R
    Bernhardt, A
    Rohr, U
    Till, E
    Wehmeier, A
    Haas, R
    Kobbe, G
    BLOOD, 2001, 98 (11) : 351B - 351B
  • [45] Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
    N W C J van de Donk
    N Kröger
    U Hegenbart
    P Corradini
    J F San Miguel
    H Goldschmidt
    J A Perez-Simon
    M Zijlmans
    R A Raymakers
    V Montefusco
    F A Ayuk
    M H J van Oers
    A Nagler
    L F Verdonck
    H M Lokhorst
    Bone Marrow Transplantation, 2006, 37 : 1135 - 1141
  • [46] Pseudothrombocytopenia after allogeneic non-myeloablative stem cell transplantation
    Gillis, S
    Eisenberg, ME
    Shapira, MY
    Or, R
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (09): : 671 - 673
  • [47] High rates of infectious complications associated with HLA-mismatched or unrelated donor allogeneic peripheral blood stem cell transplantation after non-myeloablative conditioning for patients with multiple myeloma.
    Lee, CK
    Barlogie, B
    Morris, CL
    Badros, AZ
    van Rhee, F
    Cottler-Fox, MH
    Anaissie, EJ
    Zangari, M
    Fassas, A
    Thertulien, R
    Muwalla, F
    Tricot, G
    BLOOD, 2002, 100 (11) : 859A - 859A
  • [48] Immunotransplantation for multiple myeloma using allogeneic peripheral blood stem cell transplantation
    Santos, E. S.
    Shah, S.
    Rink, J.
    Weiner, R. S.
    Miller, A. M.
    Safah, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Stem cell transplantation using non-myeloablative conditioning: Experimental and clinical experience
    Slavin, S
    Or, R
    Shapira, MY
    Prigozhina, T
    Gurevitch, O
    Nagler, A
    LEUKEMIA, 2002, 16 (03) : 415 - 415
  • [50] Non-myeloablative conditioning before allogeneic stem cell transplantation in adult acute lymphoblastic leukemia
    Gökbuget, N
    Hoelzer, D
    HAEMATOLOGICA, 2003, 88 (05) : 484 - 486
12345